Literature DB >> 33284942

Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy.

Khushali S Jhaveri1, Ilana Schlam2, Noa G Holtzman3,4, Monica Peravali2, Perry K Richardson5, Saurabh Dahiya4, Vera Malkovska2, Aaron P Rapoport4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33284942      PMCID： PMC7724903          DOI： 10.1182/bloodadvances.2020003176

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  23 in total

1.  CD19 as a therapeutic target in a spontaneous autoimmune polyneuropathy.

Authors:  P M Abraham; S H Quan; D Dukala; B Soliven
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

Review 2.  A review of chimeric antigen receptor T-cells in lymphoma.

Authors:  Jennifer Kelly Anderson; Amitkumar Mehta
Journal:  Expert Rev Hematol       Date:  2019-06-19       Impact factor: 2.929

Review 3.  Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed/refractory diffuse large B-cell lymphoma.

Authors:  Victor A Chow; Mazyar Shadman; Ajay K Gopal
Journal:  Blood       Date:  2018-06-18       Impact factor: 22.113

Review 4.  Immune Checkpoint Molecules, Personalized Immunotherapy, and Autoimmune Diabetes.

Authors:  Ciriana Orabona; Giada Mondanelli; Paolo Puccetti; Ursula Grohmann
Journal:  Trends Mol Med       Date:  2018-09-17       Impact factor: 11.951

Review 5.  Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications.

Authors:  Jean-Paul Fermand; Frank Bridoux; Angela Dispenzieri; Arnaud Jaccard; Robert A Kyle; Nelson Leung; Giampaolo Merlini
Journal:  Blood       Date:  2018-07-16       Impact factor: 22.113

6.  Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg.

Authors:  Stephan J Rüegg; Peter Fuhr; Andreas J Steck
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

7.  Immunosuppressive treatment in multifocal motor neuropathy.

Authors:  E L Feldman; M B Bromberg; J W Albers; A Pestronk
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

8.  [Multifocal motor neuropathy with conduction blocks and prurigo nodularis. A paraneoplastic syndrome in a patient with non-Hodgkin B-cell lymphoma?].

Authors:  J M Garcia-Moreno; J M Castilla; A Garcia-Escudero; G Izquierdo
Journal:  Neurologia       Date:  2004-05       Impact factor: 3.109

9.  Multifocal motor neuropathy caused by a B-cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b.

Authors:  Masaaki Noguchi; Kiyoshi Mori; Shigetaka Yamazaki; Kouichi Suda; Naotake Sato; Kazuo Oshimi
Journal:  Br J Haematol       Date:  2003-11       Impact factor: 6.998

Review 10.  In the Eye of the Storm: Immune-mediated Toxicities Associated With CAR-T Cell Therapy.

Authors:  Jorge Garcia Borrega; Philipp Gödel; Maria Adele Rüger; Özgür A Onur; Alexander Shimabukuro-Vornhagen; Matthias Kochanek; Boris Böll
Journal:  Hemasphere       Date:  2019-03-29
View more
  1 in total

Review 1.  CAR T-Cells for CNS Lymphoma: Driving into New Terrain?

Authors:  Philipp Karschnia; Jens Blobner; Nico Teske; Florian Schöberl; Esther Fitzinger; Martin Dreyling; Joerg-Christian Tonn; Niklas Thon; Marion Subklewe; Louisa von Baumgarten
Journal:  Cancers (Basel)       Date:  2021-05-20       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.